| Gene symbol | HSPB1 | Synonyms | CMT2F, HEL-S-102, HMN2B, HMND3, HS.76067, HSP27, HSP28, Hsp25, SRP27 | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q11.23 | dbXrefs | |
| Description | heat shock protein family B (small) member 1 | ||||
| GTO ID | GTC0153 |
| Trial ID | NCT01681433 |
| Disease | Prostate Cancer |
| Altered gene | Hsp27 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | OGX-427|Apatorsen |
| Co-treatment | Abiraterone Acetate|Prednisone |
| Phase | Phase2 |
| Recruitment status | Terminated |
| Title | The Pacific Clinical Trial: A Randomized Phase II Study Evaluating OGX-427 in Patients With Metastatic Castrate-Resistant Prostate Cancer (MCRPC)Who Have Prostate-Specific Antigen (PSA) Progression While Receiving Abiraterone: Hoosier Oncology Group GU12-159 |
| Year | 2012 |
| Country | Canada|United States |
| Company sponsor | Costantine Albany |
| Other ID(s) | GU12-159 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||